-
URGN Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
UroGen Pharma (URGN)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 125.99 mm | 125.99 mm | 125.99 mm | 125.99 mm | 125.99 mm | 125.99 mm |
Cash burn (monthly) | 31.60 mm | (no burn) | 7.86 mm | 9.28 mm | 9.22 mm | 8.01 mm |
Cash used (since last report) | 167.29 mm | n/a | 41.61 mm | 49.12 mm | 48.81 mm | 42.41 mm |
Cash remaining | -41.30 mm | n/a | 84.38 mm | 76.87 mm | 77.17 mm | 83.58 mm |
Runway (months of cash) | -1.3 | n/a | 10.7 | 8.3 | 8.4 | 10.4 |
13F holders | Current |
---|---|
Total holders | 142 |
Opened positions | 30 |
Closed positions | 21 |
Increased positions | 42 |
Reduced positions | 40 |
13F shares | Current |
---|---|
Total value | 367.56 bn |
Total shares | 43.63 mm |
Total puts | 9.80 k |
Total calls | 57.70 k |
Total put/call ratio | 0.2 |
Largest owners | Shares | Value |
---|---|---|
RTW Investments | 3.83 mm | $40.84 bn |
Adage Capital Partners GP, L.L.C. | 2.93 mm | $31.18 bn |
Adage Capital Management | 2.93 mm | $33.23 mm |
BlackRock | 2.47 mm | $26.28 bn |
Menora Mivtachim | 2.30 mm | $24.53 bn |
TD The Toronto-Dominion Bank | 1.75 mm | $18.63 bn |
Vestal Point Capital | 1.63 mm | $17.36 bn |
Monograph Capital Holdings Advisors | 1.57 mm | $14.17 mm |
Acorn Capital Advisors | 1.52 mm | $16.15 bn |
Pontifax Management III G.P. | 1.49 mm | $22.43 mm |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
31 Jan 25 | Barrett Elizabeth A. | RSU Ordinary Shares | Grant | Acquire A | No | No | 0 | 96,377 | 0.00 | 96,377 |
31 Jan 25 | Jason Drew Smith | Ordinary Shares | Sell | Dispose S | No | No | 11.14 | 2,767 | 30.82 k | 32,514 |
31 Jan 25 | Jason Drew Smith | Ordinary Shares | Option exercise | Acquire M | No | No | 0 | 5,500 | 0.00 | 35,281 |
31 Jan 25 | Jason Drew Smith | Ordinary Shares | Sell | Dispose S | No | No | 11.14 | 3,354 | 37.36 k | 29,781 |
31 Jan 25 | Jason Drew Smith | Ordinary Shares | Option exercise | Acquire M | No | No | 0 | 6,667 | 0.00 | 33,135 |
31 Jan 25 | Jason Drew Smith | Ordinary Shares | Sell | Dispose S | No | No | 11.14 | 1,258 | 14.01 k | 26,468 |
31 Jan 25 | Jason Drew Smith | Ordinary Shares | Option exercise | Acquire M | No | No | 0 | 2,500 | 0.00 | 27,726 |
31 Jan 25 | Jason Drew Smith | RSU Ordinary Shares | Grant | Acquire A | No | No | 0 | 10,000 | 0.00 | 10,000 |
31 Jan 25 | Jason Drew Smith | RSU Ordinary Shares | Option exercise | Dispose M | No | No | 0 | 5,500 | 0.00 | 11,000 |
31 Jan 25 | Jason Drew Smith | RSU Ordinary Shares | Option exercise | Dispose M | No | No | 0 | 6,667 | 0.00 | 6,667 |